• Unsuccessful brain cancer drugs U.S. 1998-2014 | Statistic

Health & Pharmaceuticals›
Pharmaceutical Products & Market›
Unsuccessful developing brain cancer drugs in the U.S. 1998-2014

Premium

Number of unsuccessful brain cancer drugs in development in the United States from 1998 to 2014
Exclusive Premium Statistic

Unsuccessful developing brain cancer drugs in the U.S. 1998-2014

This statistic shows the number of unsuccessful brain cancer drugs in development in the United States from 1998 to 2014. In 2011, there were six unsuccessfully developed brain cancer drugs. Since 1998, there have been 75 total medicines being developed for brain cancer that were discontinued, suspended, or had no development reported and 3 approved medications.

Show more

About this statistic

Show source

Download Settings Share

Chart type

Datalabels

Description Source More information

This statistic shows the number of unsuccessful brain cancer drugs in development in the United States from 1998 to 2014. In 2011, there were six unsuccessfully developed brain cancer drugs. Since 1998, there have been 75 total medicines being developed for brain cancer that were discontinued, suspended, or had no development reported and 3 approved medications.

Show more

Show sources information; Show publisher information
Release date: October 2014

Region: United States
Survey time period: 1998 to 2014

More information

Other interesting statistics

Time from R&D start to approval of select cancer drugs 2017

Time from R&D start to approval of select cancer drugs 2017

Time from R&D start to approval of select cancer drugs 2017

Top cancer drugs based on revenue worldwide 2016

Top cancer drugs based on revenue worldwide 2016

Top cancer drugs based on revenue worldwide 2016

Total R&D costs of select cancer drugs 2017

Total R&D costs of select cancer drugs 2017

Total R&D costs of select cancer drugs 2017

Total R&D costs including costs of capital for select cancer drugs 2017

Total R&D costs including costs of capital for select cancer drugs 2017

Total R&D costs including costs of capital for select cancer drugs 2017

Revenue as a part of R&D spending for select cancer drugs 2017

Revenue as a part of R&D spending for select cancer drugs 2017

Revenue as a part of R&D spending for select cancer drugs 2017

Revenue since approval for select cancer drugs 2017

Revenue since approval for select cancer drugs 2017

Revenue since approval for select cancer drugs 2017

Statista Accounts: Access All Statistics. Starting from $588 / Year

Prices & Access

Statistics on "U.S. pharmaceutical industry"

Contribution to global pharma

The most important statistics

Distribution of the total global pharmaceutical market sales from 2014 to 2017, by submarket*World pharmaceutical market distribution by submarket 2014-2017
Global pharmaceutical sales from 2015 to 2017, by region (in billion U.S. dollars)*World pharmaceutical sales 2015-2017 by region
Market share of top 10 national pharmaceutical markets worldwide in 2016*Market share of the leading 10 global pharmaceutical markets 2016
Growth of top 10 national pharmaceutical markets worldwide from 2011 to 2016*Top 10 global pharmaceutical markets: growth 2011-2016
Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2016 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2016
Leading countries in global life sciences mergers and acquisitions in 2017Leading countries in life sciences sector M&As 2017

Overview

The most important statistics

Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*U.S. total medicine spending 2002-2016
Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)Leading therapy areas for U.S. drug spending 2016
Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*U.S. top 20 prescribed drugs based on sales 2016
Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)Top U.S. pharma products by prescriptions 2016
Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)Pharmaceutical channel distribution by U.S. spending 2014-2016
U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*Pharmaceutical preparation manufacturing gross output 1998-2016
U.S. biopharmaceutical goods export volume from 2002 to 2016 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2016

Companies

The most important statistics

2017 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*2017 list of top U.S. biotech and pharmaceutical companies based on revenue
Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*Pharmaceutical corporations by U.S. revenue 2016
Johnson & Johnson's total revenue from 2005 to 2017 (in million U.S. dollars)Johnson & Johnson's total revenue 2005-2017
Pfizer's total revenue from 2006 to 2017 (in million U.S. dollars)Pfizer's total revenue 2006-2017
Total revenue of Merck & Co. from 2006 to 2017 (in million U.S. dollars)Merck & Co - total revenue 2006-2017
Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)Ad spending of pharmaceutical companies in the U.S. 2015
Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*Highest pharmaceutical company penalties in the U.S. 2012-2015
Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)Top pharmaceutical companies located in Canada by revenue 2016

Research and development

The most important statistics

Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2015 (in billion U.S. dollars)*Research and development expenditure: U.S. pharmaceutical industry 1995-2015
Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2015U.S. pharma industry R&D spending as a percent of total revenues 1990-2015
Number of biologic medicines in development as of June 2017, by therapeutic category*Pharmaceuticals: biologic medicines in development 2017 by category
Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*Pharmaceuticals: cost of drug development in the U.S. since 1975
Number of new molecular entities launched in the U.S. from 2003 to 2015Number of new drugs launched in the U.S. 2003-2015
Number of FDA approved orphan designations in the United States from 2000 to 2014Number of FDA approved orphan designations in the U.S. 2000-2014
New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)U.S. sales growth of new brand medicines 2011-2015
Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2013R&D expenditure per employee in U.S. sectors 2000-2013

Generics

The most important statistics

Top 20 companies based on unbranded generics U.S. market share during 2014-2015*Market share of unbranded generics by top 20 companies in U.S. 2014-2015
Change in branded and generic medication spending in the United States from 2009 to 2015 (in billion U.S. dollars)Spending change on branded and generic medicines in the U.S. 2009-2015
Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016U.S. brand and generic prescription drug revenue 2005-2016
Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016Branded vs. generic U.S. drug prescriptions dispensed 2005-2016
Savings through generic drug usage in the United States from 2007 to 2016 (in billion U.S. dollars)Savings through generic drug usage in the U.S. 2007-2016
Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*Biggest selling drugs with patent at threat in the U.S. in 2017, by revenue

Outlook

The most important statistics

Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by regionForecast of CAGR global pharmaceutical industry by region 2015-2018
Forecast of global medicine spending distribution in 2020, by region*Global spending on medicines by regional share forecast 2020
Projected global pharmaceutical sales for 2021, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2021
Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*Top branded biologic drugs in the U.S. that will go generic by 2028
Projected top 25 pharmaceutical products by U.S. revenue in 2022 (in million U.S. dollars)Leading U.S. pharmaceutical products by revenue 2022
Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2020 (in billion U.S. dollars)Healthcare and pharmaceutical industry digital ad spend in the U.S. 2011-2020

The consumer's view

The most important statistics

How is your overall impression of the U.S. pharma industry?U.S. adults impression of the U.S. pharma industry
How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?U.S. adults that believe physicians are under pressure from pharma to prescribe drugs
How would you rate the U.S. pharma companies concerning the quality of their drugs?U.S. adults impression of the U.S. pharma drug qualities
How would you rate the U.S. pharma companies concerning their fairness towards patients?U.S. adults impression of the U.S. pharma companies fairness towards patients
Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017U.S. adults who would rate selected pharma features as excellent or good 2017
Which of these pharma companies do you prefer when buying drugs?Preferred pharma companies by Americans for drug purchase 2017
Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*Americans on US pharma quality compared to foreign pharma 2017

Statista for Your Company: The Research and Analysis Tool

Product Film
Statistics
Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics.
93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Google

Samsung

Unilever

Procter and Gamble

Adobe

Telekom

PayPal

Otto

Further Content: Statistics, Studies, and Topic Pages

Statistics

Topics

Cancer care in the United Kingdom

Studies

Need help with using Statista for your research? Tutorials and first steps

Our Business Solutions: Save Time and Money

only

$588^*

per year

Your advantages

Full access to all our statistics
Download as XLS, PDF & PNG
Relevant data: complete source information

All functions of our platform illustrated face-to-face

Learn how Statista supports your company
Extensive tour across the whole portal
Personal guidance by our support team

Request webinar

The knowledge database for your company

All functions of the Premium Account
Access to dossiers, forecasts and studies
Access to our international database
Publishing rights and other exclusive functions

* All products require an annual contract.
Prices do not include sales tax
(New York residents only).

Statistics on the topic

Topics

About Statista

Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.

Internet & Telecommunications

Consumer Goods & FMCG

Retail & Trade

Travel, Tourism & Hospitality

Society

Transportation & Logistics

Learn more about how Statista can support your business.

Request webinar